Comprehensive Risk Assessment of Morbidity in Pediatric Patients Undergoing Noncardiac Surgery: An Institutional

Viviane G Nasr1, Eleonore Valencia1, Steven J Staffa1

  • 1From the Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Anesthesia and Analgesia
|October 20, 2020
PubMed

Insights

A new Risk Assessment of Morbidity in Pediatric Surgery (RAMPS) score effectively identifies children at high risk for perioperative complications. This validated tool aids in improving surgical planning and resource allocation for pediatric patients.

Area of Science:

  • Pediatric Surgery
  • Surgical Risk Assessment
  • Perioperative Morbidity

Background:

  • Developing accurate predictive models for perioperative morbidity in pediatric surgery is crucial.
  • Existing models may not fully capture the complexity of risk in young patients undergoing noncardiac procedures.

Purpose of the Study:

  • To develop and validate a comprehensive predictive model for perioperative morbidity in children undergoing noncardiac surgery.
  • To identify key factors contributing to surgical risk in pediatric patients.

Main Methods:

  • Retrospective analysis of 25,767 noncardiac surgical cases from a tertiary children's hospital (July 2017-December 2019).
  • Development of the Risk Assessment of Morbidity in Pediatric Surgery (RAMPS) score using multivariable logistic regression.
  • Internal validation via bootstrap resamples and external validation using a separate cohort.

Main Results:

  • The RAMPS score demonstrated very good predictive ability in the derivation cohort (AUC=0.805) and good external validity (AUC=0.783).
  • Key predictors included age <5 years, critically ill status, and indicators of chronic conditions (CCI ≥3, significant CCI ≥2).
  • The score effectively stratified risk, with morbidity ranging from 1.8% to 42.7%.

Conclusions:

  • The RAMPS score is a validated, 5-component tool for identifying high-risk pediatric surgical patients.
  • It offers potential to enhance perioperative planning, improve patient outcomes, and optimize healthcare resource allocation.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
161
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
187
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
259
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
159
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
105
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
138